Transplant success tied to naturally high levels of powerful immune molecule package

April 28, 2014
This is Dr. Laura L. Mulloy, Chief of the MCG Section of Nephrology, Hypertension and Transplantation Medicine and Dr. Anatolij Horuzsko, immunologist both at the Medical College of Georgia at Georgia Regents University. Credit: Phil Jones

Patients with highest levels of the most powerful version of the immune molecule HLA-G appear to have the lowest risk of rejecting their transplanted kidney, researchers report.

A study of 67 transplant patients – 50 with no evidence of rejection and 17 with chronic rejection – showed those most tolerant of their kidney had naturally high levels of HLA-G dimer, where two of the immune molecules bind together, said Dr. Anatolij Horuzsko, immunologist at the Medical College of Georgia at Georgia Regents University.

Knowing which form of HLA-G correlates with optimal transplant success could enable physicians to further tailor the delicate balance of prescribing patients sufficient immune-suppressive drugs to keep a donated organ without significantly increasing the risk of infection and cancer, said Dr. Laura L. Mulloy, Chief of the MCG Section of Nephrology, Hypertension and Transplantation Medicine.

"If we know a patient has naturally of HLA-G dimer they might need less immunosuppression which means less toxicity, less drug complications, and less cost," said Mulloy, a co-author of the study in the Journal of Immunology Research. Conversely patients with low levels might benefit from higher drug doses. "With this information, you can better customize and tailor-make your immunosuppressive cocktail."

High levels of HLA-G dimer also correlated with lower levels of inflammation, an immune response that can lead to rejection. The most successful transplants also had higher levels of HLA-G receptors, noted Horuzsko, the study's corresponding author.

While larger patient numbers are needed, the researchers' findings have continued to hold true in more than 150 at Georgia Regents Medical Center to date.

High HLA-G levels are known to correlate with successful pregnancy, HIV infection, and some cancers; low levels correlate with chronic miscarriages. Higher HLA-G levels also have been found in the blood of successful transplant patients, but the specific type was unknown, Horuzsko said.

In fact, HLA-G was thought to exist only as a single molecule until about five years ago, Horuzsko said. Functional assay technology has shown that if positioned just right, two molecules can connect and yield even more powerful tolerance.

Healthy individuals likely have very low levels of HLA-G dimer, which is part of the checks and balances of the immune response.

And, much as some fortunate people have naturally high levels of the good cholesterol, researchers now know that some generate higher levels of this powerful HLA-G package, he said.

The tradeoff is the coupling makes HLA-G dimer more fragile so Horuzsko and several biotech companies are working to develop a more stable version that could one day supplement low levels.

Transplant patients are typically prescribed a standard immunosuppressive cocktail to avoid rejecting a new kidney and it's often unclear why some transplants fail and others succeed, Mulloy said. While necessary, the drugs increase the risk of other diseases and can even be toxic to a new kidney. A drug that worked more naturally and locally, "would be perfect," Mulloy said.

Horuzsko envisions HLA-G dimer eventually being delivered directly to dendritic cells, which make decisions about what to attack and ignore. He's already successfully delivered HLA-G carrying, degradable microparticles to mice with skin grafts to enhance tolerance. Ideally, patients would need such therapy only for a few weeks until dendritic cells learn to ignore the new organ. Drugs also are available to boost expression of HLA-G receptors.

Physicians already examine HLA, or human leukocyte antigen, when identifying the best organ donor. When a patient and donor have the same or similar antigens, which are markers for what the body identifies as self and foreign, it increases the chance of a successful transplant.

Explore further: Finding may help doctors pinpoint likelihood of kidney transplant failure

Related Stories

Finding may help doctors pinpoint likelihood of kidney transplant failure

September 25, 2013
(HealthDay)—Kidney transplant patients who develop a specific type of antibody response may be at particular risk of having the organ fail within a few years, a new study suggests.

Study examines factors in pediatric kidney transplant rejection

July 18, 2011
Avoiding HLA-DR mismatching appears to be beneficial in pediatric kidney transplant patients, however the likelihood of finding a matching donor must be considered against the wait time for a possible donation, according ...

Elimination of national kidney allocation policy improves minority access to transplants

July 21, 2011
A new study published in the American Journal of Transplantation reveals that since the elimination of the kidney allocation priority for matching for HLA-B on May 7, 2003, access to kidney transplantation for minorities ...

Transplant survival could be improved by altering present criteria for matching donors, recipients

October 6, 2011
Selecting better matched recipients and donors than is currently required for umbilical-cord blood transplantation could substantially reduce transplant-related deaths. The findings, published Online First in the Lancet Oncology ...

Recommended for you

Genetic immune deficiency could hold key to severe childhood infections

July 18, 2017
A gene mutation making young children extremely vulnerable to common viruses may represent a new type of immunodeficiency, according to a University of Queensland researcher.

What are the best ways to diagnose and manage asthma?

July 18, 2017
What are the best ways to diagnose and manage asthma in adults? This can be tricky because asthma can stem from several causes and treatment often depends on what is triggering the asthma.

Large multi-ethnic study identifies many new genetic markers for lupus

July 17, 2017
Scientists from an international consortium have identified a large number of new genetic markers that predispose individuals to lupus.

Study finds molecular explanation for struggles of obese asthmatics

July 17, 2017
A large, bouquet-shaped molecule called surfactant protein A, or SP-A, may explain why obese asthma patients have harder-to-treat symptoms than their lean and overweight counterparts, according to a new study led by scientists ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Immunosuppression underlies resistance to anti-angiogenic therapy

July 14, 2017
A Massachusetts General Hospital (MGH) research team has identified a novel mechanism behind resistance to angiogenesis inhibitors - drugs that fight cancer by suppressing the formation of new blood vessels. In their report ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.